Contents & References of Studying the absorption of the anticancer drug fluorouracil on silicon carbide nanoparticle with quantum calculations
List:
Persian abstract.1
Introduction..2
Chapter one: Research overview
1-1- Statement of the problem.. 4
1-2- Nanotechnology..4
1-2-1-History of nanotechnology..4
1-2-2-Introduction of nano Technology..5
1-3-Nanomedicine..7
1-3-1-Definition of nanomedicine..7
1-2-2-Summary of nanomedicine applications.8
1-3-Nanomedicine..9
1-4-Drug design by computer.10
1-4-1-Introduction..10
1-4-2-Computational techniques in drug design and production.11
1-4-3-Appropriate software for drug design.12
1-5- Computational chemistry..13
1-5-1- Definition of computational chemistry..13
1-5-2-Methods 13
1-5-3-types of molecular models in computational chemistry. 14
1-5-4-molecular mechanics..14
1-6-drug delivery (new drug delivery)..15
1-6-1-definition of new drug delivery..15
1-6-2-carrier nanostructures. Medicine..15
1-6-3-fullerenes..16
1-6-4-liposomes..17
1-7-anticancer (anticancer)..18
1-7-1-cancer history..18
1-7-2-definition of cancer..19
1-7-3-how cancer occurs..19
1-7-4-warning signs of cancer..20
1-7-5-types of cancers..20
1-7-6-causes of cancer..21
1-7-7-cancer treatment methods..21
1-7-8-drugs Anticancer..22
1-8-5-Fluorouracil..23
1-8-1-Presentation of 5-Fluorouracil..23
1-8-2-Pharmaceutical properties of 5-Fluorouracil..25
1-9- Capecitabine...26
1-9-1-Presentation Capecitabine..26
1-10-Nanoparticles..27
1-10-1-Introduction of nanoparticles..27
1-10-2- History of nanoparticles..27
1-10-3-Properties of nanoparticles..27
1-10-4-Manufacturing methods of nanoparticles..29
1-10-5-Silicon carbide nanoparticles..30
1-11-Necessity of conducting research..31
1-12- Research objectives..32
1-13-Research variables..32
1-14- Research hypotheses..33
Chapter two: review of past texts
2-1- An overview of previous researches.34
2-2-Computational and experimental study on uracil and 5-fluorouracil.35
2-3- Investigation on the interaction of 5-fluorouracil with montmorillonite and saponite in FT-IR spectroscopy.36
2-4- Study of density function theory to investigate The effects of carbon nanotubes on the properties of the anticancer drug fluorouracil. 37 2-5- Theoretical study of the interaction of the fluorouracil anticancer drug with three nanocarriers: gold, titanium oxide, and graphene sheets. For drug delivery. 40
2-8-Drug delivery by titanium surface using biodegradable nanostructures. 41
9-2-Development of liposomal nanoparticle formulation for 5-fluorouracil, review of formulation design, pharmacokinetics and effectiveness. 42
2-10- Use of calcium phosphate granules for release system. 5-Fluorouracil. 43
Chapter 3: Research methods
3-1- Computational chemistry ..45
3-1-1- Basic calculation methods. 46
3-1-1-1- Hartree-Fack self-consistent field method. 46
3-1-1-2- Muller disorder theory- Plast. 47
3-1-2-Semi-empirical methods..47
3-1-3-Computational method of molecular mechanics.
3-4-1-Hypercam and Gosview software.52
3-4-2-Gossin software..53
3-5-Research method..54
3-6-Research results..55
3-6-1-Fluorouracil..55
3-6-2-Silicone nanoparticle carbide..63
3-6-3-silicon carbide-5-fluorouracil nanoparticle.67
Chapter four: interpretation and expression of results
4-1- analysis and expression of the results of calculations.
4-1-1-results related to the amounts of chemical coating and Mulliken charge for 5-fluorouracil molecules and silicon carbide nanoparticle according to ppm..91
4-1-2-Optimum property values ??of 5-fluorouracil molecules and silicon carbide nanoparticle..93
4-1-3-Results of optimization calculations and chemical coating and Mulliken charge of the connection structure (interaction) between 5-fluorouracil and silicon carbide nanoparticle in terms of ppm.93
4-1-4- Optimum property values Connecting structure93
4-1-4- The values ??of the optimal properties of the binding structure of 5-fluorouracil molecules with silicon carbide nanoparticle. 96
4-1-5- The results of the binding energy of 5-fluorouracil structures with silicon carbide nanoparticle. 98
Chapter Five: Discussion and suggestions
5-1- Discussion and conclusion. 100
5-2- Suggestions.102
Resources.104
English abstract. 109
Appendixes. 111
Source:
Hadizadeh, F., Khashayar Menesh, Z., 1389, Medicinal Chemistry, Mashhad: Mashhad University of Medical Sciences and Health Services, p. 1397
2. Katzong, B.M.J., Masters, S., Anthony J. Trevora., translated by Fethullahi, A., (and colleagues). Under the supervision of Jahangiri, M., 2013, basic and clinical pharmacology, Tehran: Arjamand book, pp. 522-527
3. Ebadzadeh, T., Ebrahimi, M., Zarieh, S., 1389, Carbides, Tehran: Dansh Poyan Javan
4. Naqibi, H., Dehestani, M., Shojaei, F., 2013, Introduction to Gossin software, Kerman: Kerman University Press. Properties, production and application, Isfahan: Jihad University of Isfahan Industrial Unit
6. Booker, R., Boisin, A., translated by Rezaei, A., 1388, comprehensive book of nanotechnology, Nash Gostar, p. 145
7. Mohammadi, M., Tabatabaian, S.H., Elyasi, M., Roshni, S., 2013, analysis of the formation model of the functions of the emerging technological innovation system, a case study of the nanotechnology sector, Scientific-Research Quarterly of Science and Technology Policy, Year 5, Number 4, p.22-18
Mohammadi, M., Habibollah, S., Elyasi, T., Roshshan, s., 2013, Formation of Emerging
Technological Innovation System Case of Nanotechnology Sector, Journal of Vol.8, P.1-5
9.R, Seigneuric., [etal]., 2010, From Nanotechnology to Nanomedicine: Applications to Cancer Research, Current Molecular Medicine.Vol.8, p.652 - 64
Haley, B., Frenkel, E., 2006, Nanoparticles for Drug Delivery in Cancer Treatment. Urologic Oncology: Seminars and Original Investigations, Vol. 26, p. 64 - 57
Kinzler, KW., Vogelstein, B., 2002, Genetic Basis of Human Cancer, McGraw-Hill
Kurzrock, R., Talpaz, M., 1999, Molecular Biology in Cancer Medicine, Pearson education. Harlow
Lakshmi. MS., Sherbet, GV., 1997, Genetics of Cancer: Genes Associated With Cancer Invasion, London: Metastasis and Cell Proliferation. Academic Press.
McDonald. F., Ford, C.H.G, 1997, Molecular Biology of Cancer, New York: Springer-Verlag, Incorporated
Varman.V., Bahl, Z., 1995, Synthesis of Silicon Carbide Through the Process from Different Precursors, Journal of Materials science, Vol .30, p.2693-2686
Rowland, R.E.S., [etal]., 2005, uptake and transport of nanoparticles coated with an internalin A fragment through a Caco-2 cell monolayer, Jour. Drug Del. Sci. Tech.
Casida, M.E., 1996, Recent Developments and Applications of Modern Density Functional Theory. Theoretical and Computational Chemistry, vol.4.
J?nssona, B., Wilkingb, N., 2014, New cancer drugs in Sweden: Assessment. implementation and access, Jour. Cancer Policy. Vol, 2. P. 62-45
Hosie, K. B., [etal]., 2003, A pilot study of adjuvant intraperitoneal 5-fluorouracil using 4% icodextrin as a novel carrier solution, Jour. EJSO, Vol. 29, P. 260-254
Ghoshal, K., Jacob S.T., 1997, An alternative molecular mechanism of action of 5-
Fluorouracil. a potent anticancer drug, Biochemical pharmacology, vol. 53, p. 1575-1569
Vilinska, A., [etal]., 2014, Stabilization of Silicon Carbide (SiC) micro- and nanoparticle dispersions in the presence of concentrated electrolyte, Jour. Colloid and Interface Science, Vol. 423, P. 48-53
Beabera, A.R., [etal].,2007, Nanostructured SiC by chemical vapor deposition and nanoparticle impaction, Jour.Surface & Coatings Technology.Vol.202, p.871-875
Lozano, O., [etal].,2012, Effects of SiC nanoparticles orally administered in a rat model: Biodistribution toxicity and elemental composition changes in feces and organs, Jour. Toxicology and Applied Pharmacology, Vol. 264, P.232-245
Duan, W., [etal]., 2014, Synthesis and microwave absorption properties of SiC nanowires reinforced SiOC ceramic, Jour.